CVE-2017-1604 — MEDIUM (5.4)

Vulnerability Description

IBM Maximo Anywhere 7.5 and 7.6 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 132851.

CVSS Score

5.4

MEDIUM

CVSS:3.0/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

LOW

User Interaction

REQUIRED

Scope

CHANGED

Confidentiality

LOW

Integrity

LOW

Availability

NONE

Affected Products

Vendor	Product	Versions
Ibm	Maximo Anywhere	7.5.1.2

Related Weaknesses (CWE)

CWE-79

References

http://www.ibm.com/support/docview.wss?uid=swg22011883Vendor Advisory
http://www.securityfocus.com/bid/103126Third Party AdvisoryVDB Entry
https://exchange.xforce.ibmcloud.com/vulnerabilities/132851VDB EntryVendor Advisory
http://www.ibm.com/support/docview.wss?uid=swg22011883Vendor Advisory
http://www.securityfocus.com/bid/103126Third Party AdvisoryVDB Entry
https://exchange.xforce.ibmcloud.com/vulnerabilities/132851VDB EntryVendor Advisory

FAQ

What is CVE-2017-1604?

CVE-2017-1604 is a vulnerability with a CVSS score of 5.4 (MEDIUM). IBM Maximo Anywhere 7.5 and 7.6 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potenti...

How severe is CVE-2017-1604?

CVE-2017-1604 has been rated MEDIUM with a CVSS base score of 5.4/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2017-1604?

Check the references section above for vendor advisories and patch information. Affected products include: Ibm Maximo Anywhere.